Alaunos Therapeutics, Inc. (TCRT) stock
TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.66+0.06 (+3.75%)
Close on Nov 17, 2026Market cap $4.22MP/E –Yield –
Alaunos Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Alaunos Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was -133666.7%. For fiscal 2025 it was -83520.0%, against -46790.0% the year before. The highest annual figure on record is -341.7% in fiscal 2017.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -83520.0% | −36730.0 |
| FY2024 | Dec 31, 2024 | -46790.0% | +46790.0 |
| FY2023 | Dec 31, 2023 | -93580.0% | −92288.8 |
| FY2022 | Dec 31, 2022 | -1291.2% | +18495.4 |
| FY2021 | Dec 31, 2021 | -19786.7% | +16594.8 |
| FY2018 | Dec 31, 2018 | -36381.5% | −36039.9 |
| FY2017 | Dec 31, 2017 | -341.7% | +2067.6 |
| FY2016 | Dec 31, 2016 | -2409.2% | +9607.3 |
| FY2012 | Dec 31, 2012 | -12016.5% | −2454.6 |
| FY2011 | Dec 31, 2011 | -9561.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -29766.7% | +138433.3 |
| Q1 FY2025 | Mar 31, 2025 | -53650.0% | −2315450.0 |
| Q4 FY2024 | Dec 31, 2024 | -18550.0% | +200775.0 |
| Q2 FY2024 | Jun 30, 2024 | -28225.0% | +55038.6 |
| Q1 FY2024 | Mar 31, 2024 | -168200.0% | −167895.9 |
| Q4 FY2023 | Dec 31, 2023 | 2261800.0% | +2276279.5 |
| Q2 FY2023 | Jun 30, 2023 | -219325.0% | −218180.9 |
| Q4 FY2022 | Dec 31, 2022 | -83263.6% | −82162.0 |
| Q3 FY2022 | Sep 30, 2022 | -304.1% | +806.0 |
| Q1 FY2018 | Mar 31, 2018 | -14479.5% | −13248.5 |
| Q4 FY2017 | Dec 31, 2017 | -1144.1% | – |
| Q3 FY2017 | Sep 30, 2017 | -1101.6% | – |
| Q2 FY2017 | Jun 30, 2017 | -1110.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -1230.9% | – |
See a number that looks wrong?